In this study, we evaluated ADCC activity in HIV-1-positive individuals who initiated ART at different stages of disease: before seroconversion, at CD4+ T cell counts above 350 cells/μl blood and at CD4+ T cell counts below 350 cells/μl blood (at a relevant immunodeficiency). The gene discussed is CD4; the disease is immune system disorder.